Why the study?
Does monitoring antibody levels in bulk tank milk accurately reflect the within-herd seroprevalence and changes in BVDV infection status in dairy herds?
Does monitoring antibody levels in bulk tank milk accurately reflect the within-herd seroprevalence and changes in BVDV infection status in dairy herds?
Monitoring antibody levels in bulk tank milk is a useful method for identifying changes in the BVDV infection status of a dairy herd.
BTM antibody monitoring may track BVDV herd status changes; leaves open whether it can replace seroprevalence testing in routine practice.
This study was designed to assess the relationship between antibodies against bovine viral diarrhea virus (BVDV) determined in the bulk tank milk (BTM) and the within-herd seroprevalence. We also assessed the efficiency of measuring antibody levels in BTM samples to monitor BVDV infection status in a herd. In the 81 farms included in the study, BTM samples were obtained and blood samples withdrawn from all cattle older than one year. The infection status was then determined in serum and milk using a commercial blocking ELISA based on the detection of anti-p80 antibodies. Apart from these baseline serum and milk samples, another BTM sample was collected from each herd 9 months later, and a third BTM sample obtained 9 months after this. In these second and third milk samples, anti-BVDV antibodies were determined using the same ELISA kit. Statistical tests revealed good agreement between herd seroprevalences (% seropositive animals in the herd) and the antibody levels detected in the BTM samples. During the 18 months of follow-up, the farms with persistently infected cattle at the study outset (14.8% of the herds) showed a significant decrease in BTM antibody titers after virus clearance. Conversely, a significant increase in BTM antibody levels was observed in the herds infected with BVDV during the follow-up period. Our findings indicate that monitoring antibody levels in the BTM is a useful method of identifying changes in the BVDV infection status of a herd.
No takes yet. Share an insight, caveat, or question.
Diéguez et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: